Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening.
Loading...
Embargo End Date
ICR Authors
Authors
Petralia, G
Koh, D-M
Attariwala, R
Busch, JJ
Eeles, R
Karow, D
Lo, GG
Messiou, C
Sala, E
Vargas, HA
Zugni, F
Padhani, AR
Koh, D-M
Attariwala, R
Busch, JJ
Eeles, R
Karow, D
Lo, GG
Messiou, C
Sala, E
Vargas, HA
Zugni, F
Padhani, AR
Document Type
Journal Article
Date
2021-06-01
Date Accepted
Abstract
Acknowledging the increasing number of studies describing the use of whole-body MRI for cancer screening, and the increasing number of examinations being performed in patients with known cancers, an international multidisciplinary expert panel of radiologists and a geneticist with subject-specific expertise formulated technical acquisition standards, interpretation criteria, and limitations of whole-body MRI for cancer screening in individuals at higher risk, including those with cancer predisposition syndromes. The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) proposes a standard protocol for individuals at higher risk, including those with cancer predisposition syndromes. ONCO-RADS emphasizes structured reporting and five assessment categories for the classification of whole-body MRI findings. The ONCO-RADS guidelines are designed to promote standardization and limit variations in the acquisition, interpretation, and reporting of whole-body MRI scans for cancer screening. Published under a CC BY 4.0 license Online supplemental material is available for this article.
Citation
Radiology, 2021, 299 (3), pp. 494 - 507
Rights
Source Title
Publisher
RADIOLOGICAL SOC NORTH AMERICA (RSNA)
ISSN
0033-8419
eISSN
1527-1315
Research Team
Oncogenetics
Oncogenetics
Oncogenetics